/PRNewswire/ Insilico Medicine ("Insilico"), an end-to-end artificial intelligence (AI)-driven drug discovery and development company, today announced that.
/PRNewswire/ Insilico Medicine ("Insilico"), an end-to-end artificial intelligence (AI)-driven drug discovery and development company, today announced that.
China s approval of mRNA vaccine in final stage ; effective against over 30 variants including Indian one: BioNTech CEO
Hu Yuwei Published: May 06, 2021 08:03 PM Editor s Note:
The innovative BioNTech-Fosun mRNA vaccine BNT162b2 (known as BioNTech-Pfizer vaccine in the West) has been widely used in over 65 countries and regions across the world so far, while its potential green lighting in the Chinese mainland has attracted much attention as it could be the mainland s first imported vaccine against the coronavirus disease given its promising efficacy. The Global Times reporter Hu Yuwei (GT) recently talked exclusively to the German-based vaccine developer BioNTech s CEO, Ugur Sahin (Sahin) who expressed his strong confidence in the marketing prospects of the vaccine in China. The approval has entered the final stage in the decision-making processes, and the co-developer s conversation with Chinese authorities is very encouraging, said Sahin.